Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Department of Health and Environment, Austrian Institute of Technology, Vienna, Austria.
Am J Respir Cell Mol Biol. 2021 Apr;64(4):441-452. doi: 10.1165/rcmb.2020-0270OC.
Chronic obstructive pulmonary disease (COPD) poses a major risk for public health, yet remarkably little is known about its detailed pathophysiology. Definition of COPD as nonreversible pulmonary obstruction revealing more about spatial orientation than about mechanisms of pathology may be a major reason for this. We conducted a controlled observational study allowing for simultaneous assessment of clinical and biological development in COPD. Sixteen healthy control subjects and 104 subjects with chronic bronchitis, with or without pulmonary obstruction at baseline, were investigated. Using both the extent of and change in bronchial obstruction as main scoring criteria for the analysis of gene expression in lung tissue, we identified 410 genes significantly associated with progression of COPD. One hundred ten of these genes demonstrated a distinctive expression pattern, with their functional annotations indicating participation in the regulation of cellular coherence, membrane integrity, growth, and differentiation, as well as inflammation and fibroproliferative repair. The regulatory pattern indicates a sequentially unfolding pathology that centers on a two-step failure of surface integrity commencing with a loss of epithelial coherence as early as chronic bronchitis. Decline of regenerative repair starting in Global Initiative for Chronic Obstructive Lung Disease stage I then activates degradation of extracellular-matrix hyaluronan, causing structural failure of the bronchial wall that is only resolved by scar formation. Although they require independent confirmation, our findings provide the first tangible pathophysiological concept of COPD to be further explored.Clinical trial registered with www.clinicaltrials.gov (NCT00618137).
慢性阻塞性肺疾病(COPD)对公共健康构成重大威胁,但对其详细的病理生理学知之甚少。将 COPD 定义为不可逆的肺阻塞,这更多地揭示了空间定向,而不是病理学机制,这可能是主要原因。我们进行了一项对照观察性研究,允许同时评估 COPD 的临床和生物学发展。我们调查了 16 名健康对照者和 104 名慢性支气管炎患者,其中基线时有或没有肺部阻塞。使用支气管阻塞的程度和变化作为肺组织基因表达分析的主要评分标准,我们确定了与 COPD 进展显著相关的 410 个基因。其中 110 个基因表现出独特的表达模式,其功能注释表明它们参与细胞一致性、膜完整性、生长和分化以及炎症和纤维增生性修复的调节。这种调节模式表明,病理学依次展开,其中心是表面完整性的两步失败,最早始于慢性支气管炎时上皮一致性的丧失。从全球慢性阻塞性肺疾病倡议 I 期开始,再生修复的下降继而激活细胞外基质透明质酸的降解,导致支气管壁的结构失败,只有通过瘢痕形成才能解决。尽管它们需要独立确认,但我们的发现为 COPD 的第一个有形的病理生理学概念提供了进一步探索的依据。临床试验已在 www.clinicaltrials.gov(NCT00618137)注册。